VIVA 16 : Vascular Interventional Advances

Vascular Interventional Advances (VIVA) Annual Conference 2016 is organized by Vascular Interventional Advances (VIVA) and would be held during Sep 18 - 22, 2016 at Wynn Las Vegas, Las Vegas, Nevada, United States of America.

The target audience for this CME activity is physicians who specialize in, among other areas, interventional cardiology, interventional radiology, vascular medicine, vascular surgery, cardiothoracic surgery, neurosurgery, podiatry and neuroradiology, as well as fellows, and allied health professionals (including nurses, vascular clinic staff, endovascular operating room staff, catheterization laboratory and angiography suite staff, nurse practitioners, vascular technologists, and physicians assistants)

Objectives :
At the conclusion of the course, the targeted learners should be able :
• Understand the current indications, risks, complications, and short and long-term results of various medical, interventional, and surgical therapies for the treatment of peripheral artery disease.
• Utilize new and advanced medical, endovascular, and surgical techniques and approaches to improve the care and outcomes of patients.
• Implement high quality guidelines based programs to overcome barriers to the identification and ideal care of all patients with non-cardiac vascular conditions.
• Gain and then disseminate the most current knowledge base regarding vascular care as learned from experts in the field, exposure to live cases, and data from late-breaking clinical trials.
• Increase knowledge in critical decision-making and the comprehensive spectrum of care for patients with stroke and intracranial and extracranial carotid artery disease.
• Compare and best utilize the various endovascular technologies, open surgical techniques, and hybrid approaches, including risks and complications, for the treatment of patients with aortic diseases.
• Enhance the understanding of venous physiology, anatomy, diseases, and management options across a variety of venous anatomies and pathology.
• Understand state-of-the-art diagnosis and treatment strategies that are consistent with findings in newly reported clinical trials.